The health food industry has entered the blue ocean era

With the rapid development of China's economy in the past 40 years, China's GDP has grown to the second place in the world, and China's per capita GDP has also been growing. The economic growth has led people to pay more and more attention to their medical health. On the 19th, the reporter learned from the interview of the 8th China (Guangzhou) International Health Care Industry Expo, which was just closed in Guangzhou, that China's health industry has entered the blue ocean era, and Chinese companies have taken the opportunity to accelerate to the international market.

It is reported that with the strategic goal of “Healthy China” in the “13th Five-Year Plan”, the medical and health industry is being paid more and more attention by people, regular physical examination, health care, health care... People’s attention to medical health is increasing. China's pharmaceutical health industry has already stood on the "window".

At present, the output value of China's health service industry only accounts for about 5% of GDP. The output value of health service industry in developed countries accounts for more than 10% of GDP. The development potential of China's health service industry is huge. According to statistics, the Chinese medicine industry, including Chinese medicine industry, agriculture, commerce, food and health products, and other products, have developed rapidly. The output value has increased from more than 700 billion yuan in 2009 to 1.2 trillion yuan in 2013. By 2020, it will reach 3 trillion yuan; some people in the industry said that China's health food industry has entered the blue ocean era.

The 8th China (Guangzhou) International Health Care Industry Expo was held in Guangzhou Pazhou Complex in September. This highly-watched exhibition attracted more than 1,220 companies from 15 countries and regions. The exhibition was approved by the Ministry of Commerce. China's largest health food exhibition, this year's exhibition attracted brands from health care, natural and organic foods, imported foods, hydrogen health products, health care products and other health fields, including Korea, Malaysia, Thailand, Indonesia, Turkey, Australia, Canada, Companies from Kazakhstan, New Zealand, Italy, and some Russian-speaking countries participated in the exhibition.

The reporter learned that not only many overseas companies have targeted China's huge health food market; the Chinese health food enterprises that have achieved rapid development in recent years have also actively entered overseas; at this exhibition, health food products have been the main products of previous exhibitions, occupying the exhibition. Half of the country. Among them, enzymes, special medical foods, sarcophagus, traditional Chinese medicine tonics, probiotics and other categories are the most concerned.

Zhu Caihong, head of Guangzhou Zhongke, said in an interview that Zhongke Lingzhi is the leading enterprise in China's Ganoderma lucidum health care industry. Since its establishment in 1984, Zhongke Lingzhi has been a natural product integrating raw material cultivation, processing and production. Health food enterprises have now become one of the strongest R&D companies in the domestic health food industry.

Zhu Rainbow introduced that Zhongke Group, which has achieved rapid development in China, has been paying close attention to overseas markets. In recent years, it has actively participated in the highest-level commercial exhibitions in the country such as the Canton Fair and Shenzhen High-Tech Fair. Its main products such as Ganoderma lucidum spore oil are widely used overseas. Welcome; At this Guangzhou International Health Care Industry Expo, there are also many guests who come to the booth of China Science and Technology Co., Ltd. to learn about Zhongke products and production technology.

According to the "Healthy China 2030" Plan Outline issued by the State Council in 2016, the scale of China's health service industry will exceed 8 trillion yuan and 16 trillion yuan in 2020 and 2030. The promotion of “One Belt, One Road” has effectively promoted the development of the Chinese medicine health industry and the growth of international trade. China Customs statistics show that in 2014, the total import and export of Chinese medicine products reached US$4.63 billion, an increase of 9.79% year-on-year, of which exports amounted to US$3.592 billion, an increase of 14.49% year-on-year. (Finish)

Source: China News Network

Antipyretic & Analgesic

Antipyretic & Analgesic,Paracetamol Injection,Injection For Antipyretic,Injection For Analgesic

Shandong Qidu Pharmaceutical Co., Ltd. , https://www.qdyypharma.com